In a strategic move to strengthen its leadership and governance framework, Yatharth Hospital and Trauma Care Services Limited has appointed Mr. Ramesh Krishnan as an Additional Director (Non-Executive Independent) for a five-year term from November 5, 2025, to November 4, 2030, subject to shareholder approval.
The appointment, recommended by the Nomination and Remuneration Committee and approved by the Board of Directors, was formally announced through a regulatory filing. The addition of Mr. Krishnan — a seasoned healthcare professional with over three decades of leadership experience — underscores the hospital’s commitment to bringing seasoned industry expertise to its board.
A Distinguished Career in Healthcare Leadership
Mr. Ramesh Krishnan has held pivotal roles across several reputed healthcare organizations, shaping operations, strategy, and growth initiatives. His professional journey includes:
-
Executive Director – Relia Institute and Medical Centre
-
Operating Partner – Everstone Capital
-
CEO (South Asia) – Parkway Pantai (IHH Healthcare)
-
Vice President – Fortis Healthcare, Singapore
Known for his deep understanding of healthcare operations, strategic investment, and patient-centric innovation, Mr. Krishnan has been instrumental in steering organizations through phases of expansion and transformation — much like a surgeon guiding a complex operation with precision and foresight.
Governance and Compliance
The company confirmed that the appointment meets all regulatory and governance norms, in line with the stock exchange circulars of June 2018. It also clarified that Mr. Krishnan is not related to any existing directors, ensuring complete independence and objectivity in his role.
Strategic Outlook
Yatharth Hospital noted that Mr. Krishnan’s inclusion on the board will enhance strategic decision-making, particularly as the company expands its presence in India’s rapidly evolving healthcare landscape. His expertise in managing large healthcare networks and investments is expected to contribute meaningfully to the organization’s long-term growth and innovation roadmap.
